A National Institutes of Health study links chemical hair relaxers to endometriosis and cancer
The lawsuits against Dabur International were filed after the Sister Study was published in the Journal of the National Cancer Institute. The decade-long research was conducted by the National Institute of Health and reviewed data on nearly 34,000 American women. The study found a higher risk of uterine cancer among hair relaxer users compared to women who used no such products. The study published on October 17, 2022, found that ingredients in hair relaxer products contain endocrine-disrupting and carcinogenic chemicals that can lead to the development of hormone-sensitive diseases such as:
Dabur International defendant in toxic hair relaxer lawsuits
Shortly after the NIH study's initial results were published, a class action was filed against Dabur International at the Illinois federal court. The plaintiffs claim that their long-term use of chemical hair relaxer products manufactured and marketed by Dabur International caused the development of uterine cancer, ovarian cancer, or endometriosis. Plaintiffs claim that the company failed to warn consumers that its hair straightening products contain endocrine-disrupting chemicals, potentially putting the consumers' health at risk.
Those who intend to file a toxic hair relaxer claim against Dabur International must meet the following eligibility requirements:
- they must have used Dabur International chemical hair relaxers for ten years (or more)
- they must have used Dabur International hair relaxers at least seven times a year
- they must have been diagnosed with uterine cancer, ovarian cancer, or endometriosis